Protagonist Therapeutics Inc buy Truist Financial Co.
Start price
10.08.26
/
50%
€130.00
Target price
10.08.27
€147.14
Performance (%)
2.31%
Price
19.08.26
€133.00
Summary
This prediction is currently active. The BUY prediction by Truist_Financial_Co_ shows slight gains of 2.31%. This prediction currently runs until 10.08.27. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Protagonist Therapeutics Inc | 0.000% |
| iShares Core DAX® | -1.059% |
| iShares Nasdaq 100 | -2.387% |
| iShares Nikkei 225® | -4.361% |
| iShares S&P 500 | -1.778% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Protagonist Therapeutics Inc diskutieren
Protagonist Therapeutics (PTGX) was given a new $170.00 price target by Truist Financial Corporation. They now have a "buy" rating on the stock.
Ratings data for PTGX provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for Protagonist Therapeutics Inc
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€66.00
28.10.25
28.10.25
€75.49
28.10.26
28.10.26
101.52%
19.08.26
19.08.26
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€50.50
11.03.25
11.03.25
€70.01
11.03.26
11.03.26
66.34%
12.03.26
12.03.26
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€50.50
09.09.24
09.09.24
€54.34
09.09.25
09.09.25
4.95%
10.09.25
10.09.25